HCW Biologics Inc.

HCWB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$30,024-$24,994-$14,901-$12,862
Dep. & Amort.$1,184$1,135$718$544
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,009$1,004$1,120$361
Change in WC$13,603-$4,643$2,488$1,455
Other Non-Cash-$0$4,984$188-$473
Operating Cash Flow-$14,227-$22,514-$10,386-$10,976
Investing Activities
PP&E Inv.-$262-$6,203-$10,275-$47
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$34,972
Inv. Sales/Matur.$0$10,000$24,984$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$262$3,797$14,708-$35,019
Financing Activities
Debt Repay.$6,786-$38$6,448$0
Stock Issued$6,463$24$16$56,030
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2,320$0-$191-$6,760
Financing Cash Flow$15,569-$15$6,273$49,269
Forex Effect$0$0$0$0
Net Chg. in Cash$1,079-$18,731$10,596$3,275
Supplemental Information
Beg. Cash$3,595$22,326$11,731$8,456
End Cash$4,675$3,595$22,326$11,731
Free Cash Flow-$14,489-$28,717-$20,661-$11,023